Evaluating adherence to ESC guidelines for Chronic Coronary Syndrome
Chronic Coronary Syndrome Snapshot Study
This study looks at how well doctors are following the latest guidelines for treating chronic coronary syndrome in adults to see what helps or hinders their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European Society of Cardiology Research network |
| Locations | 1 site (Yerevan) |
| Trial ID | NCT06748924 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how well healthcare professionals follow the 2019 European Society of Cardiology (ESC) Guidelines on Chronic Coronary Syndrome (CCS). It will evaluate adherence across various healthcare settings and identify barriers and facilitators to implementing these guidelines. The study will enroll adult patients with confirmed or suspected CCS to gather data on current practices and outcomes. The findings will help inform targeted interventions to improve guideline adherence and patient care.
Who should consider this trial
Good fit: Ideal candidates include adults with suspected coronary artery disease, new onset heart failure, or those within one year after an acute coronary syndrome.
Not a fit: Patients with a recent acute coronary syndrome or those with unrelated conditions that limit participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care for patients with Chronic Coronary Syndrome by improving adherence to established guidelines.
How similar studies have performed: Other studies have shown success in evaluating guideline adherence, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with angina and/or dyspnoea, and suspected coronary artery disease. * Patients with new onset of heart failure or reduced left ventricular function. * Patients within 1 year after an acute coronary syndrome or recent revascularisation. * Patients beyond 1 year after initial diagnosis or revascularisation. * Patients with Angina with No Obstructive Coronary Artery disease (ANOCA)(e.g., microvascular angina, vasospastic angina). * Asymptomatic subjects referred for screening for coronary artery disease. Exclusion Criteria: * Patients with a recent acute coronary syndrome (defined as those within 1 month of a diagnosis of unstable angina, non-ST-segment elevation myocardial infarction or ST-segment elevation myocardial infarction). * Patients with conditions unrelated to CCS that significantly limit their ability to participate in the study or interfere with the assessment of guideline adherence. * Patients participating in any clinical study where the protocol recommends deviations from guidelines recommendations.
Where this trial is running
Yerevan
- Erebouni Medical Center — Yerevan, Armenia (Recruiting)
Study contacts
- Study coordinator: Emilie Head of Department
- Email: registries@escardio.org
- Phone: +33489872018
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.